|HOME CONTACT US LINKS ARMY MEDICINE A-Z SITEMAP ARMY.MIL AKO SEARCH|
|USAMRIID: Biodefense Solutions to Protect our Nation|
Welcome to our webpage, and thank you for your interest in the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The dedicated members of the USAMRIID staff are proud to share information on our nationally important research program.
Since its inception in 1969, USAMRIID has spearheaded research to develop medical solutions—vaccines, drugs, diagnostics, and information—to protect our military service members from biological threats. Our specialized capabilities include Biosafety Level 3 and Level 4 laboratories, world-class expertise in the generation of biological aerosols for testing candidate vaccines and therapeutics, and fully accredited animal research facilities.
The outstanding national reputation of USAMRIID has been built over the years by numerous scientists and technical staff working to protect both military personnel and civilians from the threat of infectious diseases. We participate in support of emerging disease investigations, working alongside colleagues from the Centers for Disease Control and Prevention and the World Health Organization. As a reference laboratory for the Department of Defense, we set the standard for identification of biological agents. Our customers in the Army and the Department of Defense know us as a "tech base" organization that has produced some 20 candidate medical products over the past decade. Still others recognize the impressive scientific credentials of our workforce, which represents some of the top infectious disease and biological defense experts in the Nation—indeed, in the world.
As the United States continues a new era of civilian biodefense research, it is also clear that USAMRIID plays a critical role in the status of our country's preparedness for biological terrorism and biological warfare. While our primary mission is to protect the warfighter, our research benefits civilians as well.
USAMRIID is looking forward to continued collaborations with industry partners and with other federal agencies—including the Department of Health and Human Services and the Department of Homeland Security—to develop medical countermeasures that will protect all of our citizens, both military and civilian. I'm excited about our future and confident that together, we can accomplish great things.
Welcome to USAMRIID—the birthplace of medical biodefense.